Viscumneoside III

CAS No. 118985-27-6

Viscumneoside III( —— )

Catalog No. M31590 CAS No. 118985-27-6

Viscumneoside III, a dihydroflavone O-glycoside, is a potent Tyrosinase inhibitor with an IC50 of 0.5 mM. Viscumneoside III has anti-angina pectoris.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Viscumneoside III
  • Note
    Research use only, not for human use.
  • Brief Description
    Viscumneoside III, a dihydroflavone O-glycoside, is a potent Tyrosinase inhibitor with an IC50 of 0.5 mM. Viscumneoside III has anti-angina pectoris.
  • Description
    Viscumneoside III, a dihydroflavone O-glycoside, is a potent Tyrosinase inhibitor with an IC50 of 0.5 mM. Viscumneoside III has anti-angina pectoris.
  • In Vitro
    Viscumneoside III (1.0 mg/mL) has the inhibition activitie on tyrosinase of 77% . Viscumneoside III is used as a material for cosmetics with whitening function.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    118985-27-6
  • Formula Weight
    596.53
  • Molecular Formula
    C27H32O15
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2-Amino-3-hydroxypyr...

    2-Amino-3-hydroxypyridine as a chromogenic reagent for the spectrophotometric determination of osmium.

  • N-Formyl-Nle-Leu-Phe...

    N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist.Potent chemoattractant for human neutrophils.Radioiodinated molecule has full biological activity.

  • Saprisartan

    Saprisartan is an AT1 receptor antagonist. It is based on medications of losartan's prototypical chemical structure.